Roa, Shawn Michael .

HRN: 23-65-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/04/2023
09/10/2023
IVT
265mg
Q6hrs
Pcap C; T/c CHD
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: